Manisha Talukdar

750 total citations · 1 hit paper
11 papers, 243 citations indexed

About

Manisha Talukdar is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Manisha Talukdar has authored 11 papers receiving a total of 243 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 4 papers in Molecular Biology and 4 papers in Physiology. Recurrent topics in Manisha Talukdar's work include Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers), Asthma and respiratory diseases (4 papers) and interferon and immune responses (2 papers). Manisha Talukdar is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers), Asthma and respiratory diseases (4 papers) and interferon and immune responses (2 papers). Manisha Talukdar collaborates with scholars based in Canada, United States and United Kingdom. Manisha Talukdar's co-authors include Frank Sicheri, Christina Gaughan, Robert H. Silverman, Beihua Dong, Hao Huang, Nicole M. Duffy, Daniel Y.L. Mao, Babal K. Jha, Monica C. Pillon and Andrey A. Perelygin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Molecular Cell.

In The Last Decade

Manisha Talukdar

9 papers receiving 243 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Heightened long-term cardiovascular risks after exacerbation of chronic obstructive pulmonary disease

2024 34 citations Nathaniel M. Hawkins, Clémentine Nordon et al. Heart profile →

Peers

Manisha Talukdar

MB

IMMUN

PRM

CCM

PHYSI

Anne Steglich Germany

Josephine Nemegeer Belgium

Riley Williams United States

A. Floto United Kingdom

Gil Metser United States

Samad Hashimi United States

Johnstone Makale United Kingdom

Yanwen Xu China

Konstantinos D. Alysandratos United States

Anne Steglich Germany

Manisha Talukdar

89 ×0.6

MB

28 ×0.3

IMMUN

18 ×0.4

PRM

39 ×1.0

CCM

11 ×0.4

PHYSI

Citations per year, relative to Manisha Talukdar Manisha Talukdar (= 1×) peers Anne Steglich

Countries citing papers authored by Manisha Talukdar

Since Specialization

Citations

This map shows the geographic impact of Manisha Talukdar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manisha Talukdar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manisha Talukdar more than expected).

Fields of papers citing papers by Manisha Talukdar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manisha Talukdar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manisha Talukdar. The network helps show where Manisha Talukdar may publish in the future.

Co-authorship network of co-authors of Manisha Talukdar

This figure shows the co-authorship network connecting the top 25 collaborators of Manisha Talukdar. A scholar is included among the top collaborators of Manisha Talukdar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manisha Talukdar. Manisha Talukdar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Hawkins, Nathaniel M., Clémentine Nordon, Manisha Talukdar, et al.. (2025). Healthcare resource utilisation in patients with exacerbations of COPD and associated cardiovascular events: the EXACOS-CV study. ERJ Open Research. 11(6). 1212–2024.

2.

Duong, MyLinh, Christina Qian, Manisha Talukdar, et al.. (2025). Frequency and severity of COPD exacerbations and future risk of exacerbations and mortality: an observational cohort study in Canada. BMJ Open Respiratory Research. 12(1). e002976–e002976.

3.

Bhutani, Mohit, et al.. (2025). Short-acting beta agonist, antibiotics, oral corticosteroid and association with mortality and cardiopulmonary events in patients with COPD: a retrospective cohort study in Alberta, Canada. BMJ Open. 15(1). e083451–e083451. 1 indexed citations

4.

Bhutani, Mohit, et al.. (2024). Short-Acting Beta-Agonists, Antibiotics, Oral Corticosteroids, and the Associated Burden of COPD. SHILAP Revista de lepidopterología. 2(3). 100042–100042. 1 indexed citations

5.

Hawkins, Nathaniel M., Clémentine Nordon, Kirsty Rhodes, et al.. (2024). Heightened long-term cardiovascular risks after exacerbation of chronic obstructive pulmonary disease. Heart. 110(10). 702–709. 34 indexed citations breakdown →

6.

Mayers, Irvin, Christina Qian, Manisha Talukdar, et al.. (2023). Asthma-related emergency admissions and associated healthcare resource use in Alberta, Canada. BMJ Open Respiratory Research. 10(1). e001934–e001934. 3 indexed citations

7.

Noorduyn, Stephen G., Christina Qian, Karissa Johnston, et al.. (2022). SABA use as an indicator for asthma exacerbation risk: an observational cohort study (SABINA Canada). ERJ Open Research. 8(3). 140–2022. 15 indexed citations

8.

Daou, Salima, Manisha Talukdar, Jinle Tang, et al.. (2020). A phenolic small molecule inhibitor of RNase L prevents cell death from ADAR1 deficiency. Proceedings of the National Academy of Sciences. 117(40). 24802–24812. 21 indexed citations

9.

Tang, Jinle, Yingjie Wang, Huan Zhou, et al.. (2020). Sunitinib inhibits RNase L by destabilizing its active dimer conformation. Biochemical Journal. 477(17). 3387–3399. 11 indexed citations

10.

Banerjee, Shuvojit, Elona Gusho, Christina Gaughan, et al.. (2019). OAS-RNase L innate immune pathway mediates the cytotoxicity of a DNA-demethylating drug. Proceedings of the National Academy of Sciences. 116(11). 5071–5076. 50 indexed citations

11.

Huang, Hao, Elton Zeqiraj, Beihua Dong, et al.. (2014). Dimeric Structure of Pseudokinase RNase L Bound to 2-5A Reveals a Basis for Interferon-Induced Antiviral Activity. Molecular Cell. 53(2). 221–234. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact